Editor of Patient Care Online.
New Scientific Statement from American Heart Association Raises Awareness of CVD Risks for Women
Women with adverse pregnancy outcomes face a significantly higher risk of cardiovascular disease and stroke later in life, according to the statement.
Young Infants, Children Born Prematurely Face Highest Risk for RSV Hospitalization: Daily Dose
Your daily dose of the clinical news you may have missed.
Preventive Health Screenings Continue to Lag Post-Pandemic: Daily Dose
SGLT2 Inhibitors Outperformed Other Oral Antidiabetic Drugs for Patients with T2D and NAFLD, According to New Research
Findings suggest that SGLT2 inhibitors may be the preferred choice for patients with both T2D and NAFLD, reported researchers.
Tirzepatide Linked to “Impressive” BP Reduction in Adults with Obesity: Daily Dose
COVID-19 Hospitalization Linked to Higher Long-Term Mortality Risk Compared to Seasonal Influenza, Shows New Research
Hospitalization for COVID-19 was associated with higher long-term risks of death, adverse health outcomes, and significant cumulative excess DALYs vs influenza.
Cannabis Use and Risk of Prevalent Asthma: Daily Dose
13 Drugs Approved for Primary Care in 2023
Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.
Depression, IBD Combo Raises Risk of Hospital Readmission, Mortality: Daily Dose
Younger Infants and Children Born Prematurely at Highest Risk for RSV Hospitalization, According to New Study
Results showed nearly one-third of hospitalizations for acute respiratory illness among children aged <5 years were associated with RSV.
Survey Data Underscores Education Gap in Ulcerative Colitis for Primary Care Clinicians: Daily Dose
Noninvasive Tests May be Poor Predictor of Liver Fibrosis, Especially Among Black Adults
Using FIB-4 index first to screen for cirrhosis may lead to clinicians missing 48% of cases, according to a recent study.
Vagus Nerve Stimulation in Narcolepsy: Daily Dose
CDC: Gonorrhea Cases Declined for First Time in Decade, but Syphilis Keeps Climbing
Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.
Migraine-Related Stigma Impacts Quality of Life: Daily Dose
Updated Monovalent COVID-19 Vaccines Effective Against Symptomatic Infection, Emerging Variants
The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection, according to new data from the CDC.
HbA1c Greater than 6.0% Raises T2D Risk in Children with Obesity: Daily Dose
Depression Severity Linked to Higher Odds of Asthma, COPD, and Respiratory Symptoms
The risk of cough and asthma in persons with severe depression was 3.32 times and 2.84 times higher, respectively, than that in those without depression, reported researchers.
Gabapentinoid Use Increasing in US: Daily Dose
FDA Renews Warning Against Use of Tianeptine-Containing Products, aka “Gas Station Heroin”
Reported adverse events of products with tianeptine include seizures, loss of consciousness, and death, according to the FDA.
Daily Dose: Outpatient C. difficile Underdiagnosed in US
Dupilumab Safe for Patients with Moderate-to-Severe Asthma for up to 6 Years
New data suggest that dupilumab is safe for long-term use among patients with moderate-to-severe asthma or OCS-dependent severe asthma.
Daily Dose: Vaccination Reduces Risk of Long COVID in Children
Daily Dose: Gabapentinoids & Risk of Severe COPD Exacerbations
New Study Highlights Primary Drivers of Cost of Inflammatory Bowel Disease Care
Unplanned emergency service and medication utilization make up the majority of costs of IBD care, reported researchers.
Daily Dose: Bempedoic Acid Linked to 20% Reduction in Total CV Events
Survey Data Highlight Need for Education on Ulcerative Colitis Among Primary Care Clinicians
Survey findings presented at the Crohn’s & Colitis Congress suggest a need for education among some health care specialists about the clinical presentation of ulcerative colitis.
Gabapentinoid Use Increasing in US Despite Concerns Over Coprescribing, Off-Label Use
Gabapentinoid use increased from 4.0% of the population reporting use of the medication in 2015 to 4.7% in 2021, according to new data.
Daily Dose: Childhood Stress & Risk for Cardiometabolic Disease
New Research Suggests Outpatient C. difficile May be Underdiagnosed in US
Findings showed a high incidence of outpatient Clostridioides difficile infection despite a low rate of testing.